Literature DB >> 20177992

International stem cell registries.

Joeri Borstlap1, Mai X Luong, Heather M Rooke, B Aran, A Damaschun, A Elstner, Kelly P Smith, Gary S Stein, Anna Veiga.   

Abstract

Rapid advances in stem cell research have led to the derivation of hundreds of human embryonic stem (hES) cell lines in centers throughout the world, as well as the development of new technologies for producing pluripotent stem cells. These cell lines have unique characteristics and were derived using a variety of ethical guidelines. Stem cell registries have been developed in order to collect, organize, and disseminate cell line-specific information. In this review, we describe the current state of the field by providing an overview of the unique qualities and mandates of the three major stem cell registries: the European hES Cell Registry, the Registry of hES Cell Line Provenance developed by the International Society for Stem Cell Research, and the International Stem Cell Registry of hES and induced pluripotent stem cell lines established at the University of Massachusetts Medical School. While each registry has its own unique mandate and features, there is some overlap in the goals and information provided. This review discusses the challenges and prospects for an integrated approach in which all three registries effectively collaborate to minimize duplication and facilitate information exchange within the stem cell community.

Entities:  

Mesh:

Year:  2010        PMID: 20177992     DOI: 10.1007/s11626-010-9295-1

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  4 in total

1.  The changing landscape of European and international regulation on embryonic stem cell research.

Authors:  A Elstner; A Damaschun; A Kurtz; G Stacey; B Arán; A Veiga; J Borstlap
Journal:  Stem Cell Res       Date:  2008-11-17       Impact factor: 2.020

2.  Development of a European human embryonic stem cell registry.

Authors:  J Borstlap; A Kurtz; G Stacey; A Elstner; A Damaschun; B Arán; J C Gerlach; J C Izpisúa; A Veiga
Journal:  Regen Med       Date:  2008-11       Impact factor: 3.806

Review 3.  Human embryonic stem cell registries: value, challenges and opportunities.

Authors:  Mai X Luong; Kelly P Smith; Gary S Stein
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

4.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.

Authors:  Oluseun Adewumi; Behrouz Aflatoonian; Lars Ahrlund-Richter; Michal Amit; Peter W Andrews; Gemma Beighton; Paul A Bello; Nissim Benvenisty; Lorraine S Berry; Simon Bevan; Barak Blum; Justin Brooking; Kevin G Chen; Andre B H Choo; Gary A Churchill; Marie Corbel; Ivan Damjanov; Jon S Draper; Petr Dvorak; Katarina Emanuelsson; Roland A Fleck; Angela Ford; Karin Gertow; Marina Gertsenstein; Paul J Gokhale; Rebecca S Hamilton; Ales Hampl; Lyn E Healy; Outi Hovatta; Johan Hyllner; Marta P Imreh; Joseph Itskovitz-Eldor; Jamie Jackson; Jacqueline L Johnson; Mark Jones; Kehkooi Kee; Benjamin L King; Barbara B Knowles; Majlinda Lako; Franck Lebrin; Barbara S Mallon; Daisy Manning; Yoav Mayshar; Ronald D G McKay; Anna E Michalska; Milla Mikkola; Masha Mileikovsky; Stephen L Minger; Harry D Moore; Christine L Mummery; Andras Nagy; Norio Nakatsuji; Carmel M O'Brien; Steve K W Oh; Cia Olsson; Timo Otonkoski; Kye-Yoon Park; Robert Passier; Hema Patel; Minal Patel; Roger Pedersen; Martin F Pera; Marian S Piekarczyk; Renee A Reijo Pera; Benjamin E Reubinoff; Allan J Robins; Janet Rossant; Peter Rugg-Gunn; Thomas C Schulz; Henrik Semb; Eric S Sherrer; Henrike Siemen; Glyn N Stacey; Miodrag Stojkovic; Hirofumi Suemori; Jin Szatkiewicz; Tikva Turetsky; Timo Tuuri; Steineke van den Brink; Kristina Vintersten; Sanna Vuoristo; Dorien Ward; Thomas A Weaver; Lesley A Young; Weidong Zhang
Journal:  Nat Biotechnol       Date:  2007-06-17       Impact factor: 54.908

  4 in total
  9 in total

1.  Stem cell banking: between traceability and identifiability.

Authors:  Bartha M Knoppers; Rosario Isasi
Journal:  Genome Med       Date:  2010-10-05       Impact factor: 11.117

2.  The National Stem Cell Therapy Patient Registry of Malaysia--measuring clinical outcomes of stem cell therapy.

Authors:  Seng Cheong Loke; Sze Piaw Chin; Sarojini Sivanandam; Pik Pin Goh; Richard Kwong Fai Ng; Khay Yong Saw; Teck Onn Lim
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 3.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Authors:  Kevin G Chen; Barbara S Mallon; Ronald D G McKay; Pamela G Robey
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

Review 4.  A survey of parameters involved in the establishment of new lines of human embryonic stem cells.

Authors:  Ana Maria Fraga; Érica Sara Souza de Araújo; Raquel Stabellini; Naja Vergani; Lygia V Pereira
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

Review 5.  Allogenic banking of dental pulp stem cells for innovative therapeutics.

Authors:  Pierre-Yves Collart-Dutilleul; Franck Chaubron; John De Vos; Frédéric J Cuisinier
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

6.  From banking to international governance: fostering innovation in stem cell research.

Authors:  Rosario Isasi; Bartha M Knoppers
Journal:  Stem Cells Int       Date:  2011-09-05       Impact factor: 5.443

Review 7.  The use of pluripotent stem cell for personalized cell therapies against neurological disorders.

Authors:  Hye-Yeong Ha; Si-Hyong Jang; Ji-Won Jung
Journal:  J Biomed Biotechnol       Date:  2011-12-13

8.  Registration of human embryonic stem cell lines: Korea, 2010.

Authors:  Ji-Yoon Lee; Dae-Yeon Lee; Young-Sil Choi; Kyoung-Jae Lee; Yong-Ou Kim
Journal:  Osong Public Health Res Perspect       Date:  2011-08-02

9.  Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements.

Authors:  Maroussia Lévesque; Jihyun Rosel Kim; Rosario Isasi; Bartha Maria Knoppers; Aurora Plomer; Yann Joly
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.